Redefine what’s possible in life sciences
To address the changing needs of patients, rising costs, demands for new treatments, and the need for accelerated R&D innovation, life sciences organizations must adopt a modern transformation approach.
Life sciences now
100%
of Biopharma executives agree AI foundation models will enable connections across data types, revolutionizing where and how AI is used
78%
New Science, the best in science and health technology is expected to drive 78% of revenue growth in the next five years
92%
of Biopharma executives agree that data transparency is becoming a competitive differentiator
>50
drugs discovered through AI are progressing through clinical pipelines with two approved treatments projected to generate more than $1 billion in revenue by 2028
60%
of life sciences supply chain executives want better real-time inventory and visibility from external manufacturing partners
Welcome a new era of science and technology in biopharma
Science and technology convergence is rapidly changing the ways we interact with our physical and digital worlds, bringing forth a step change in the speed of industry innovation. Four tech trends are redefining the boundaries and driving this transformation.
How to reinvent life sciences
Accelerate innovation, drive productivity, and transform patient outcomes
Fulfill unmet patient needs with innovative and effective treatments
Cultivate new ways of working, innovating, collaborating and operating
Build a resilient supply chain to deliver high quality therapies and devices
Shift towards smart technology-centric products and redefine how data is utilized to improve patient care
Run your business with compliant, patient-centric, intelligent operations
Reinvent commercial models to better meet patients’ and HCPs’ needs
What’s trending in life sciences
Awards and recognition
Market Leader in Horizon 3 Life Sciences Service Providers Report
Position #1: Life Sciences Smart Manufacturing Services Lead
Our life sciences leaders
Petra Jantzer, Ph.D.
Senior Managing Director – Global Life Sciences Lead
Ramon Pressburger
Managing Director – North America Lead and Strategy Lead, Global Life Sciences
Jan Ising
Managing Director – Europe, Global Life Sciences
Tom Kawalec
Managing Director – Global Life Sciences Medical Technology Lead, North America Lead